DNA Discrimination: Fixing the Fears of Genetic Testing
By Olivia Nash,
Brown Political Review Magazine
| 12. 13. 2017
Genetic testing is one of the most groundbreaking technologies of the modern age. The advent of human genome sequencing has expanded medical research and enabled services such as 23andMe to offer affordable and accessible snapshots of an individual’s genetic risks. Despite the newfound ease of testing, concerns about privacy and fears of discrimination have stopped many people from getting tested or participating in medical research. The laws currently in place to guard against genomic discrimination have glaring loopholes, and out of their own financial interest, health insurance providers and employers have argued for scaling back those protections. However, genetic testing’s potentially revolutionary effects on modern medicine and individual health are too great for the fear of genetic discrimination to stand in its way. The government, rather than scaling back protections, should work to expand genetic privacy rights to encourage the testing necessary to achieve the promises of personalized medicine.
Predictive genetic testing was first offered to the population on a broad scale in the 1990s, when breast cancer was found to correlate with a mutated BRCA1/2 gene. This specific discovery...
Related Articles
By Courtney Withers and Daryna Zadvirna, ABC News | 12.03.2025
Same-sex couples, single people, transgender and intersex West Australians will be able to access assisted reproductive technology (ART) and surrogacy, almost a decade after reforms were first promised.
The landmark legislation, which removes the requirement for people to demonstrate medical...
By Grace Won, KQED [with CGS' Katie Hasson] | 12.02.2025
In the U.S., it’s illegal to edit genes in human embryos with the intention of creating a genetically engineered baby. But according to the Wall Street Journal, Bay Area startups are focused on just that. It wouldn’t be the first...
By Emma Cieslik, Ms. Magazine | 11.20.2025
Several recent Biopolitical Times posts (1, 2, 3, 4) have called attention to the alarmingly rapid commercialization of “designer baby” technologies: polygenic embryo screening (especially its use to purportedly screen for traits like intelligence), in vitro gametogenesis (lab-made eggs and sperm), and heritable genome editing (also termed embryo editing or reproductive gene editing). Those three, together with artificial wombs, have been dubbed the “Gattaca stack” by Brian Armstrong, CEO of the cryptocurrency company...